# Arrow Electronics (ARW) — Financial Analysis

**Exchange:**   
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-10  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ARW/thesis · /stocks/ARW/memo

## Financial Snapshot

---
source: coverage-next-full
step: 04
ticker: ARW
company: Arrow Electronics, Inc.
generated: 2026-06-09
---

### Step 04 — Financial Quality & Adversarial Sweep
#### Arrow Electronics, Inc. (ARW)

---

#### 1. Income Statement Quality Adjustments

##### Key Adjustments Required

**1. Restructuring & Amortization (Non-GAAP Adjustments)**

Arrow reports both GAAP and non-GAAP metrics; the reconciliation items are:

| Adjustment | FY2025 | FY2024 | Nature |
|-----------|--------|--------|--------|
| Restructuring/integration charges | $116M | $143M | Operating Expense Efficiency Plan + legacy |
| Purchase accounting amortization | ~$10M | ~$12M | Acquisition-related |
| **Non-GAAP Operating Income** | **$948M** | **$1,002M** | vs. GAAP $822M / $769M |
| **Non-GAAP EPS** | **$11.02** | **$10.56** | vs. GAAP $10.93 / $7.29 |

**Judgment:** The FY2025 GAAP EPS ($10.93) actually exceeds non-GAAP EPS ($11.02) — unusual. This is because the restructuring program resulted in tax benefits and write-downs that made GAAP results better than non-GAAP. In FY2024, GAAP EPS of $7.29 significantly trailed non-GAAP $10.56 because restructuring charges were higher relative to earnings.

For valuation purposes, use non-GAAP EPS as it removes non-recurring charges; but the restructuring program through FY2026 is real cash expense.

**2. ECS Revenue Recognition**

Global ECS net revenue of $9.4B understates the scale of ECS activities. Gross billings were ~$22.1B in FY2025. Arrow acts as agent for most software transactions. This means:
- ECS revenue growth rate is more meaningful than absolute level
- ECS margins (11.4%) appear high but are earned on a smaller base vs. gross-basis reporters
- Comparing to TD SYNNEX (reports gross) requires adjustment [S1]

**3. FX Impact**

FY2025 FX changes increased revenues by +$399M (+1.4%), operating income by +$21.6M, and EPS by $0.31. On a constant-currency basis:
- FY2025 revenue growth: ~+9.1% (vs. reported +10.5%)
- FY2025 op income growth: ~+4.0% (vs. reported +7.0%)

This is meaningful given 66% of sales are non-US; FX is a persistent noise factor. [S1]

**4. FY2025 Operating Cash Flow Anomaly**

FY2025 reported operating CF of only $64M vs. net income of $571M — a large negative working capital swing. This reflects strong revenue acceleration in H2 2025 (especially Q4), which drove higher accounts receivable and inventory balances. This is not a quality concern; it's a working-capital-intensive recovery pattern. FY2024 had exceptional $1.1B OCF because receivables/inventory were contracting during the downturn.

Quality test: For distributors, compare OCF across the cycle:
- FY2022 (peak, OCF negative -$33M): Working capital consumed cash as inventory built
- FY2024 (trough, OCF $1.1B): Working capital released cash as inventory wound down
- FY2025 (recovery, OCF $64M): Inventory rebuilding as demand surged
- FY2026 Q1 (OCF $700M in one quarter): Strong earnings + early working capital normalization

Pattern is consistent with a working-capital-intensive distributor operating normally. [S3]

---

#### 2. Balance Sheet Quality Assessment

| Metric | FY2025 | FY2024 | Assessment |
|--------|--------|--------|-----------|
| Net Debt | $2.78B | $2.59B | Manageable; ~2.0x EBITDA leverage |
| Working Capital | $7.44B | $6.69B | Healthy; 21.3% of sales |
| Debt/EBITDA | ~2.9x GAAP / ~2.3x non-GAAP | ~2.8x | At high end but within guided range |
| Committed/Undrawn Liquidity | >$2.5B | — | Strong liquidity buffer |
| Goodwill | ~$2.5B (est.) | — | Acquisition-related; material |

**Inventory Risk:** ~56% of consolidated inventories covered by supplier price protection; ~59% by supplier repurchase arrangements. The remaining ~41–44% is exposed to obsolescence and price erosion. Given the fast-moving nature of semiconductor pricing, this creates tail risk in severe downcycles. [S1]

---

#### 3. Cash Flow Quality

| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|--------|--------|--------|--------|--------|
| EBITDA | $2,256M | $1,652M | $932M | $960M |
| Operating CF | ($33M) | $705M | $1,130M | $64M |
| CapEx | ($79M) | ($83M) | ($93M) | ($101M) |
| Free Cash Flow | ($112M) | $622M | $1,037M | ($37M) |
| FCF/Net Income | N/M | 68.8% | 264% | (6.5%) |

**Observation:** Distribution businesses generate FCF when revenue is declining (inventory winds down) and consume cash when revenue is rising (inventory rebuilding). The cycle-avg FCF picture is what matters for valuation, not any single-year figure. Cycle-average FCF (FY2022–2025): ~$388M/yr. [S3]

---

#### 4. Adversarial Research Sweep

*Note: No earnings transcripts available (coverage-next-full path). Adversarial sweep based on SEC filings, press releases, and web research.*

##### Known Issues / Historical Incidents

**4a. BIS Entity List Incident (Q4 2025)**
Three Arrow Chinese subsidiaries were temporarily added to the U.S. Bureau of Industry and Security (BIS) Entity List on October 8, 2025, restricted U.S. technology exports to those entities. Arrow was removed from the list by October 17, 2025 — only 9 days. Management stated "marginal" lost sales in Asia/Pacific Q4 2025 and no anticipated future impact. [S1]

**Assessment:** Resolved quickly; no material financial impact. However, it demonstrates the tail risk of doing 29% of revenue in Asia/Pacific with significant China exposure. If a re-listing occurred for longer, Asia/Pacific Components revenue could face material disruption.

**4b. Non-Cancellable ECS Purchase Obligations (Ongoing)**
Global ECS entered non-cancellable multi-year purchase obligations through 2032 as exclusive partner for certain products. These underperformed in FY2025, causing $18.3M in losses. Management guided that "additional losses anticipated in coming quarters." [S1]

**Assessment:** Material ongoing risk. The contractual structure limits Arrow's ability to exit unprofitable ECS arrangements for years. This is the most significant financial quality concern identified.

**4c. CEO Transition (Ongoing)**
Sean Kerins departed as President and CEO in September 2025. William F. Austen appointed as Interim CEO. Permanent search underway as of the FY2025 10-K filing. [S1]

**Assessment:** Operationally managed; Austen's open-market stock purchases ($601K in February 2026) signal alignment. Governance risk: strategy continuity and M&A decision-making are uncertain until a permanent CEO is named.

**4d. Tax Reserves and TCJA**
Arrow disclosed ongoing settlements related to the Tax Cuts and Jobs Act and OECD Pillar Two global minimum tax rules. Effective tax rate was 20.6% in FY2025 (non-GAAP: 21.7%). No material adverse settlements disclosed; range of uncertain tax positions not individually material. [S1]

**4e. Environmental and Legal**
No material environmental litigation flagged in FY2025 10-K. Standard product liability and trade compliance risks exist but are disclosed as non-material. No significant short-seller reports or class action lawsuits identified via web research. [S1, S4]

##### Short Interest / Skeptical View
Short interest of 2.64% of float with 1.78 days to cover as of June 2026 — very low. No evidence of significant short-seller campaigns against ARW. The low short interest suggests the market does not perceive material fraud or structural deception risk. [S2]

---

#### 5. Quality Assessment Summary

| Dimension | Rating | Notes |
|-----------|--------|-------|
| Revenue recognition | Good | Components gross/ECS net — appropriate; disclosed clearly |
| Earnings quality | Good | Non-GAAP adjustments are identified and recurring-but-transparent |
| Balance sheet integrity | Good | Goodwill ~$2.5B; no evidence of aggressive asset inflation |
| Cash flow reliability | Cyclical | Distributor working capital cycle causes large swings; cycle-avg normalizes |
| Legal/governance risk | Moderate | CEO transition + ECS obligations are active risks |
| Fraud/manipulation risk | Low | 15 years of audited financials; no short-seller campaigns; EY as auditor |

**Overall Financial Quality: B+ (Good with Cyclical Noise)**

---

#### 6. Source Index

| ID | Source | Detail |
|----|--------|--------|
| S1 | SEC 10-K FY2025 | MD&A, non-GAAP reconciliation, BIS incident, ECS obligations, CEO transition |
| S2 | Consensus data file | Short interest, analyst ratings |
| S3 | XBRL + StockAnalysis | Cash flow quality, cycle analysis |
| S4 | Web research | No material short-seller reports identified |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ARW/fundamental

## Navigation

- Overview: /stocks/ARW
- Financials (this page): /stocks/ARW/financials
- Thesis: /stocks/ARW/thesis
- Investment Memo: /stocks/ARW/memo
- Coverage universe: /stocks